NRIX - Nurix Therapeutics, Inc.
17.08
0.590 3.454%
Share volume: 1,116,174
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$16.49
0.59
0.04%
View ratios
| Fiscal Date | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 05-31-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 07-11-2024 | 10-11-2024 | 01-28-2025 | 04-08-2025 | 07-09-2025 | 10-09-2025 | 01-28-2026 | 04-08-2026 | |
| Total revenue | 12.092 M | 12.588 M | 13.284 M | 18.453 M | 44.056 M | 7.894 M | 13.577 M | 6.252 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 12.092 M | 12.588 M | 13.284 M | 18.453 M | 44.056 M | 7.894 M | 13.577 M | 6.252 M | |
| 4.10% | 5.53% | 38.91% | 138.75% | -82.08% | 71.99% | -53.95% | |||
| Operating expenses | 60.632 M | 67.199 M | 77.941 M | 81.317 M | 92.378 M | 99.279 M | 96.672 M | 98.747 M | |
| Selling general and admin | 11.710 M | 11.718 M | 10.717 M | 11.654 M | 14.282 M | 13.159 M | 13.648 M | 14.610 M | |
| Research and development | 48.922 M | 55.481 M | 67.224 M | 69.663 M | 78.096 M | 86.120 M | 83.024 M | 84.137 M | |
| Total expenses | 60.632 M | 67.199 M | 77.941 M | 81.317 M | 92.378 M | 99.279 M | 96.672 M | 98.747 M | |
| 10.83% | 15.99% | 4.33% | 13.60% | 7.47% | -2.63% | 2.15% | |||
| Operating income | -48.540 M | -54.611 M | -64.657 M | -62.864 M | -48.322 M | -91.385 M | -83.095 M | -92.495 M | |
| Ebit | -48.540 M | -54.611 M | -64.657 M | -62.864 M | -48.322 M | -91.385 M | -83.095 M | -92.495 M | |
| Pretax income | -44.456 M | -48.874 M | -58.541 M | -56.351 M | -42.704 M | -86.421 M | -78.221 M | -87.174 M | |
| 9.94% | 19.78% | -3.74% | -24.22% | 102.37% | -9.49% | 11.45% | |||
| Income tax | 90.000 K | 82.000 K | 8.000 K | 0.000 | 760.000 K | 0.000 | 0.000 | 0.000 | |
| Net income basic | -44.546 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||||
| Net income | -44.546 M | -48.956 M | -58.549 M | -56.351 M | -43.464 M | -86.421 M | -78.221 M | -87.174 M | |
| -9.90% | -19.60% | 3.75% | 22.87% | -98.83% | 9.49% | -11.45% |